$HDSN

Hudson Technologies (HDSN) Q3 2026 Earnings Call Transcript

Hudson Technologies (HDSN) reported Q3 2026 revenue of $59.4M, down 20% YoY, with net income of $2M ($0.05 EPS), compared to $12.4M ($0.27 EPS) in 2025. The company signed a joint development agreement with Icorium for advanced refrigerant separation technology and secured a $210M DLA contract extension. Hudson remains debt-free with $35.3M in cash, focusing on strategic growth and operational improvements. Management reaffirmed 2026 gross margin targets of low to mid-20%.

Original reporting
Published Oct 29, 2026, 4:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 4:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hudson Technologies (HDSN) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$HDSNBearishMed
01

Why it matters

The earnings miss may trigger a sell‑off, but the strategic partnership and contract renewal could mitigate longer‑term risk.

02

Market read

Earnings release provides fresh data for traders; short‑term downside risk dominates, but strategic initiatives may offer a longer‑term upside narrative.

03

What to watch

The $210M DLA contract renewal provides multi‑year revenue stability and may support future upside if execution succeeds.

Relevance 7/10Novelty 8/10Timing: after‑hours earnings release

Background

Hudson Technologies (HDSN) provided its Q3 2026 earnings call transcript, highlighting revenue decline, margin pressures, a re‑awarded defense contract, and a new joint development agreement.

Company-level read

Ticker impact

$HDSNBearishMedium confidence
Context

Q3 2026 earnings call disclosed $59.4M revenue, 20% YoY decline, $2M net income and a $11M contribution from the re‑awarded $210M DLA contract.

Expected impact

likely downward pressure as investors price in weaker sales and margin compression

Evidence & confidence

Revenue fell 20% YoY and pricing weakness in HFC refrigerants hurt profitability; no new growth catalyst announced.

Market effects

Refrigerant recovery sector may see broader pricing pressure as HFC demand weakens.

U.S. industrial segment could face margin compression amid regulatory phase‑down of HFCs.

Limited; impact confined to niche refrigerant and environmental compliance markets.

Counterpoint

The joint development with Icorium could unlock higher‑margin specialty refrigerant products, offsetting short‑term revenue weakness.

Key entities

  • Hudson Technologies

    US‑listed provider of refrigerant recovery and purification services.

  • Icorium

    Kansas‑based developer of mixed refrigerant separation technology.

  • DLA

    Defense Logistics Agency, awarded a $210M contract to Hudson.

Related articles

$HDSNMedAI 8/10

Hudson Technologies Q3 Earnings Call Highlights

Hudson Technologies (HDSN) reported Q3 with $35.3M in cash, up $10M from June. The company is prioritizing investments over share buybacks. Inventory conditions are affecting HFC pricing and demand. Management sees potential demand from data centers and HFO blends. Hudson signed a tech development agreement and won a $210M government contract.

$HDSNMed

HUDSON TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS

HUDSON TECHNOLOGIES INC /NY (HDSN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 HUDSON TECHNOLOGIES REPORTS THIRD QUARTER 2026 RESULTS Entered into Joint Development Agreement to Advance Next-generation Separation Technology Re-awarded DLA contract valued at $210 million Debt-free with $35.3 million in cash Maintaining Full Year Gross Margin Tar

$HDSNMedAI 8/10

Hudson Technologies (HDSN) Q2 2026 Earnings Call Transcript

Hudson Technologies (HDSN) reported Q2 2026 revenue of $78.3 million, up 8% year over year, on 12% higher sales volume. Average refrigerant prices fell 6%, pressuring gross margin to 26% from 31% in Q2 2025. Net income was $4.9 million ($0.12/share) versus $10.2 million ($0.23) a year earlier. Full-year gross margin guidance was revised to low-to-mid 20%.

$HDSNMed

Hudson Technologies Q2 Earnings Call Highlights

Hudson Technologies (NASDAQ:HDSN) reported Q2 revenue of $78.3 million, up 8% year over year, with sales volume up 12% but average refrigerant selling price down 6%. Gross margin fell to 26% from 31% a year earlier. The company revised its FY2026 gross-margin target to the low-to-mid-20% range and said the Defense Logistics Agency re-awarded a five-year $210 million contract.

$HDSNMed

Hudson Technologies (NASDAQ:HDSN) Surprises With Q2 CY2026 Sales

Hudson Technologies (NASDAQ:HDSN) reported Q2 CY2026 revenue of $78.35 million, up 7.5% year on year and 5.6% above Wall Street estimates, according to the company. GAAP EPS was $0.12, below consensus and down from $0.23 a year earlier. Management cited selling-season growth despite HFC price weakness and inflation. Shares fell 1.5% to $6.12 after the release.

$HDSNMed

HUDSON TECHNOLOGIES REPORTS SECOND quarter 2026 reSults

HUDSON TECHNOLOGIES INC /NY (HDSN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 HUDSON TECHNOLOGIES REPORTS SECOND quarter 2026 reSults Second quarter revenue grew 8% driven by strong volume Posts trailing twelve month double-digit volume growth Operations fully restored at tornado impacted facility Announces Icorium partnership Maintains unleve